TrialMolecular oncology2019

AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxel.

Anieta M Sieuwerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.